Total Funding
85
84
Total FundingPost-IPO Equity raised
Growth Score 85 in past quarter
-1 pts
Heat Score 84 in past quarter
20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
16551
Atossa Therapeutics is a biopharmaceutical company that develops therapies for breast cancer and conditions.
- Heather Rees: Chief Financial Officer
- Janet Rea: SVP of Research and DevelopmentPast Role: AVM Biotechnology, SVP of Regulatory Affairs
About the Company
Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on breast cancer and other breast conditions. They offer treatment for pre-cancerous breast conditions and early-stage breast cancer.
